BluePath Capital Management
ABT icon

BluePath Capital Management’s Abbott ABT Stock Holding History

BluePath Capital Management’s Portfolio ABT Stock Details ABT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.35M Buy
13,697
+676
+5% +$70.6K 0.71% 52
2026
Q2 		$1.18M Buy
13,021
+1,269
+11% +$116K 0.65% 59
2026
Q1 		$1.21M Buy
11,752
+2,260
+24% +$255K 0.83% 36
2025
Q4 		$1.19M Buy
9,492
+1,709
+22% +$218K 0.8% 37
2025
Q3 		$1.04M Buy
7,783
+1,213
+18% +$159K 0.76% 48
2025
Q2 		$894K Buy
6,570
+251
+4% +$33.1K 0.79% 49
2025
Q1 		$838K Sell
6,319
-2,960
-32% -$377K 0.87% 26
2024
Q4 		$1.05M Buy
9,279
+1,800
+24% +$208K 0.56% 43
2024
Q3 		$853K Buy
7,479
+1,520
+26% +$167K 0.53% 51
2024
Q2 		$619K Buy
5,959
+2,044
+52% +$217K 0.43% 72
2024
Q1 		$445K Buy
3,915
+602
+18% +$69K 0.34% 79
2023
Q4 		$379K Sell
3,313
-192
-5% -$19.2K 0.32% 72
2023
Q3 		$339K Buy
+3,505
New +$368K 0.31% 65

Other funds holding ABT

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $19.7B AUM 7.08% 1-Year Est. Return

BluePath Capital Management's ABT Position: Q3 2026 in Review

BluePath Capital Management increased its Abbott (ABT) stake by 5.2% in Q3 2026, buying an estimated $70.6K and bringing the position to 13,697 shares worth $1.35M. The position accounts for 0.71% of the portfolio, ranked #52.

BluePath Capital Management first reported a position in ABT in Q3 2023 and has held it in 13 quarters since. 2,164 funds tracked by Wall St. Rank hold ABT as of Q3 2026.

  • BluePath Capital Management held 13,697 shares of Abbott worth $1.35M as of Q3 2026.
  • BluePath Capital Management bought 676 Abbott shares in Q3 2026, an estimated $70.6K.
  • Abbott made up 0.71% of BluePath Capital Management's portfolio in Q3 2026, its #52 holding.
  • BluePath Capital Management first reported a position in Abbott in Q3 2023 and has held it in 13 quarters since.
  • 2,164 funds tracked by Wall St. Rank held Abbott as of Q3 2026.

Based on BluePath Capital Management's 13F filing for Q3 2026, filed 26 Oct 2026.